s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid has been researched along with Asthma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berkenkopf, JW; Carlson, RP; Grimes, D; Kreft, AF; Marinari, LR; Musser, JH; Sturm, RJ; Weichman, BM | 1 |
| Berkenkopf, JW; Chang, JY; Grimes, D; Heaslip, RJ; Sturm, RJ; Weichman, BM | 1 |
1 review(s) available for s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid and Asthma
| Article | Year |
|---|---|
WY-50,295 tromethamine: a novel inhibitor of leukotriene-mediated reactions.
Topics: Animals; Antigens; Asthma; Bronchoconstriction; Calcimycin; Guinea Pigs; Humans; Leukotrienes; Lipoxygenase Inhibitors; Lung; Macrophages; Mice; Naphthaleneacetic Acids; Neutrophils; Quinolines; Rats; Receptors, Immunologic; Receptors, Leukotriene; SRS-A; Zymosan | 1991 |
1 other study(ies) available for s(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid and Asthma
| Article | Year |
|---|---|
WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Topics: Administration, Oral; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Asthma; Female; Guinea Pigs; Humans; Hydroxyurea; Indoles; Leukocytes; Leukotriene B4; Lipoxygenase Inhibitors; Macrophages; Male; Mice; Naphthaleneacetic Acids; Prostaglandin-Endoperoxide Synthases; Quinolines; Rabbits; Rats; Rats, Wistar | 1993 |